DOCSLIB.ORG

Medmen Enterprises, Inc. Form 424B3 Filed 2021-07-20

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medmen Enterprises, Inc. Form 424B3 Filed 2021-07-20 SECURITIES AND EXCHANGE COMMISSION FORM 424B3 Prospectus filed pursuant to Rule 424(b)(3) Filing Date: 2021-07-20 SEC Accession No. 0001829126-21-006507 (HTML Version on secdatabase.com) FILER MedMen Enterprises, Inc. Mailing Address Business Address 10115 JEFFERSON 10115 JEFFERSON CIK:1776932| IRS No.: 981431779 | State of Incorp.:A1 | Fiscal Year End: 0630 BOULEVARD BOULEVARD Type: 424B3 | Act: 33 | File No.: 333-256912 | Film No.: 211099426 CULVER CITY CA 90232 CULVER CITY CA 90232 SIC: 5990 Retail stores, nec 4243302082 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Filed Pursuant to Rule 424(b)(3) Registration No. 333-256912 MEDMEN ENTERPRISES INC. 135,371,705 Class B Subordinate Voting Shares This prospectus relates the offer and sale or other disposition from time to time of up to an aggregate of 135,371,705 Class B Subordinate Voting Shares (the “Subordinate Voting Shares”) of MedMen Enterprises Inc. by the selling shareholders named in this prospectus, (together with their respective donees, transferees or other successors in interest, referred to as the “selling shareholders”), which consists of 34,639,071 Subordinate Voting Shares, 63,951,112 Subordinate Voting Shares issuable upon exercise of warrants, and 36,781,522 Subordinate Voting Shares issuable upon conversion of convertible notes (the “Resale Shares”). Registration of the Resale Shares does not mean that the selling shareholders will actually offer or sell any of these shares. We will not receive any proceeds from the sale or other disposition of the Resale Shares offered by the selling shareholders. We will, however, receive the exercise price of any warrants exercised for cash. To the extent that we receive cash upon exercise of any warrants, we expect to use that cash for working capital and general corporate purposes. The selling shareholders or their transferees may, from time to time, sell, transfer or otherwise dispose of any or all of their Subordinate Voting Shares or interests in Subordinate Voting Shares on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. For additional information, you should refer to the section entitled “Plan of Distribution” of this prospectus. We are paying all expenses of registration incurred in connection with this offering, except any underwriting discounts and commissions incurred by the selling shareholders. Our Subordinate Voting Shares trade on the Canadian Securities Exchange (“CSE”) under the symbol “MMEN”. The closing sales price of our Subordinate Voting Shares on the CSE on July 14, 2021 was C$0.3350 per share. Our Subordinate Voting Shares also trade on the OTCQX under the symbol “MMNFF.” The last reported sales price of our Subordinate Voting Shares on the OTCQX on July 14, 2021 was $0.2676 per share. We are an “emerging growth company”, as defined under the federal securities laws and, as such, we may continue to elect to comply with certain reduced public company reporting requirements in future reports. Certain implications of being an “emerging growth company” are described on page 3 of this prospectus. Investing in our Subordinate Voting Shares involves a high degree of risk. You should refer to the discussion of risk factors, beginning on page 10 of this prospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. This prospectus is dated July 16, 2021 Table of Contents Table of Contents Page ABOUT THIS PROSPECTUS 1 PROSPECTUS SUMMARY 2 OVERVIEW 2 THE OFFERING 4 FORWARD-LOOKING INFORMATION 6 RISK FACTORS 10 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document USE OF PROCEEDS 24 DIVIDEND POLICY 24 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 25 BUSINESS 77 PROPERTIES 107 LEGAL PROCEEDINGS 109 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 110 EXECUTIVE COMPENSATION 115 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE 118 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 120 SELLING SHAREHOLDERS 122 DESCRIPTION OF CAPITAL STOCK 125 PLAN OF DISTRIBUTION 130 LEGAL MATTERS 137 EXPERTS 137 WHERE YOU CAN FIND MORE INFORMATION 137 FINANCIAL STATEMENTS F-1 i Table of Contents ABOUT THIS PROSPECTUS As permitted under the rules of the Securities and Exchange Commission, or the SEC, this prospectus includes important business information about MedMen Enterprises Inc. that is also contained in documents that we file with the SEC. A prospectus supplement may also add, update or change information included in this prospectus. Any statement contained in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in such prospectus supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. You should rely only on the information contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. You may obtain copies of these documents, without charge, from the website maintained by the SEC at www.sec.gov, as well as other sources. See “Where You Can Find More Information.” Before you invest in our securities, you should read carefully the registration statement (including the exhibits thereto) of which this prospectus forms a part, this prospectus, any prospectus supplement, or any accompanying prospectus supplement. You should rely only on the information contained in this prospectus. Neither we nor the selling shareholder have authorized anyone to provide you with additional or different information from that contained in this prospectus. We and the selling shareholder take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should assume that the information contained in this prospectus is accurate only as of any date on the front cover of this prospectus regardless of the time of delivery of this prospectus, or any applicable prospectus supplement, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those dates. The Resale Shares are being offered to sell, and offered to buy only in jurisdictions where offers and sales are permitted. We have not taken any action to permit a public offering of our Subordinate Voting Shares or the possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy securities, in any jurisdiction where the offer or sale is not permitted. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus. References herein to “MedMen Enterprises”, “MedMen” or the “Company”, “we”, “us” or “our” refer to MedMen Enterprises Inc. and its subsidiaries. In this prospectus, currency amounts are stated in U.S. dollars (“$”), unless specified otherwise. All references to C$ are to Canadian dollars. 1 Table of Contents Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document PROSPECTUS SUMMARY This summary highlights information contained throughout this prospectus. This summary does not contain all of the information that should be considered before investing in our securities. Investors should read the entire prospectus carefully, including the more detailed information regarding our business, the risks of purchasing our securities discussed in this prospectus. Investors should read the entire prospectus carefully. See “Risk Factors” beginning on page 10 of this prospectus. OVERVIEW General MedMen is a cannabis retailer based in the U.S. with flagship locations in Los Angeles, Las Vegas, Chicago, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores and proprietary delivery service, as well as curbside and in-store pick up. The Company currently operates 22 store locations across California (12), Florida (5), Nevada (3), Illinois (1), and Arizona (1), and four retail locations located within the state of New York were classified as discontinued operations. The Company’s retail stores are located in strategic locations across key cities and neighborhoods in each of its markets. The Company has plans to open additional retail stores over the next twelve months, including, but not limited to the following cities: ● San Francisco, CA ● Morton Grove, IL ● Boston, MA ● Newton, MA ● Miami, FL ● Jacksonville, FL ● Orlando, FL ● Deerfield Beach, FL ● Tampa, FL The Company expects to continue strengthening its pipeline of stores through acquisitions, partnerships and applications for new licenses, with a focus on recreational states such as California, Nevada and Illinois and medical states such as Florida. On June 1, 2021, the West Hollywood Business License Commission approved MedMen’s Legacy Medical Business application, which will enable the Company to continue operating its flagship location in West Hollywood both as a medical and adult-use retailer. The Company anticipates receiving its new license in the coming weeks. At its Oak Park, IL retail location, the Company plans to open its expanded retail with an additional 3,332 square feet, bringing the location to a total of 7,732 square feet, and a highly visible street facing storefront.
Load more

Recommended publications
  • Oregon Liquor Control Commission
    Downloaded March 8, 2019 from https://www.oregon.gov/olcc/marijuana/Pages/default.aspx OREGON LIQUOR CONTROL COMMISSION Marijuana Business Licenses Approved as of 3/8/2019 Retail Medical LICENSE NUMBER LICENSEE NAME BUSINESS NAME LICENSE TYPE ACTIVE COUNTY Delivery Grade Hemp 050 100037147CC Hotbox Farms LLC Hotbox Farms Recreational Retailer Yes Baker Yes 050 10011127277 Scott, Inc 420VILLE Recreational Retailer Yes Baker 020 10017768FC7 Burnt River Farms, LLC Burnt River Farms LLC. Recreational Producer Yes Baker 030 10031846B25 Burnt River Farms, LLC Burnt River Farms LLC. Recreational Processor Yes Baker 060 1003692E356 Burnt River Farms, LLC Burnt River Farms LLC. Recreational Wholesaler Yes Baker 050 1003713A8A4 The Coughie Pot, LLC The Coughie Pot Recreational Retailer Yes Baker 050 10047883377 Sumpter Nugget, LLC Sumpter Nugget Recreational Retailer Yes Baker Yes 030 10071310CDB Nugget Candy Co, LLC Nugget Candy Co, LLC Recreational Processor Yes Baker 060 10079080A50 420BUNKERVILLE LLC 420 Bunkerville Recreational Wholesaler Yes Baker 060 1010135EC04 Hotbox Farms LLC Hotbox Farms Recreational Wholesaler Baker 020 10001223B25 Fire Creek Farms LLC. Fire Creek Farms Recreational Producer Yes Benton 020 100013554D9 Country Grow, LLC Country Grow Recreational Producer Yes Benton 020 1000140D286 Bosmere Farms, Inc. Bosmere Farms, Inc. Recreational Producer Yes Benton 020 10004312ECD Grasshopper Farm LLC Cascade Valley Cannabis Recreational Producer Yes Benton 020 1001124042C Apollo Grown Inc. Apollo Grown Inc. Recreational Producer
    [Show full text]
  • The Sex Issue Highly Devoted Cannabis Matchmaking and Life Coaching
    EMERALD MAGAZINE EMERALD MAGAZINE EmeraldBOUTIQUE CANNABIS CULTURE SEX, NUGS AND ROCK BOUTIQUE CANNABIS CULTURE CULTURE CANNABIS BOUTIQUE N’ ROLL GETTIN’ DOWN AND HIGH WITH POPULAR MUSIC THEEMERALDMAGAZINE.COM The Sex Issue Highly Devoted Cannabis Matchmaking and Life Coaching Sunnabis: A Love Story for the Strains Fortify Your Heart with a Bittersweet Valentine’s Day Cocktail CANNABIS | LIFESTYLE | TRAVEL | CUISINE THE EMERALD MAGAZINE.COM Got Flowers? Download the app and search for that perfect brand for that perfect person. Let us be your plug. Own a brand and want to be listed? Call Weedmaps 800-938-1392 Letter from the Publisher Dear Reader, Thank you for picking up the February issue of the Emerald Magazine. This month, things are getting a little steamy PUBLISHER CHRISTINA DE GIOVANNI (and smoky) here at the office, as we explore the connection between cannabis and sex. MANAGING EDITOR JAANA PRALL Love is all about chemistry, but so is cannabis… combine the two, and the possibilities are endless. EDITOR-AT-LARGE MELISSA HUTSELL GIFT GUIDE SHILOH WISHAM People all over the world have found love through the industry. Now, couples can celebrate their love for each GRAPHIC DESIGNER SIERRA FONG | NATHAN WELLS other, and the herb, in true canna-style. All the products needed for cannabis-themed nuptials -- from hemp dresses to Bud Bars – are showcased at the Cannabis Wedding Expo (Pg. 20), coming to San Francisco this February and Los COVER SHOT KENESHA FACELLO Angeles in March. The science of cannabis is still in its infancy, but research has so far shown us that the plant’s therapeutic benefits CONTRIBUTORS extend into the bedroom.
    [Show full text]
  • The Sex Issue Highly Devoted Cannabis Matchmaking and Life Coaching
    EMERALD MAGAZINE EMERALD MAGAZINE EmeraldBOUTIQUE CANNABIS CULTURE SEX, NUGS AND ROCK BOUTIQUE CANNABIS CULTURE CULTURE CANNABIS BOUTIQUE N’ ROLL GETTIN’ DOWN AND HIGH WITH POPULAR MUSIC THEEMERALDMAGAZINE.COM The Sex Issue Highly Devoted Cannabis Matchmaking and Life Coaching Sunnabis: A Love Story for the Strains Fortify Your Heart with a Bittersweet Valentine’s Day Cocktail CANNABIS | LIFESTYLE | TRAVEL | CUISINE THE EMERALD MAGAZINE.COM Got Flowers? Download the app and search for that perfect brand for that perfect person. Let us be your plug. Own a brand and want to be listed? Call Weedmaps 800-938-1392 Letter from the Publisher Dear Reader, Thank you for picking up the February issue of the Emerald Magazine. This month, things are getting a little steamy PUBLISHER CHRISTINA DE GIOVANNI (and smoky) here at the office, as we explore the connection between cannabis and sex. MANAGING EDITOR JAANA PRALL Love is all about chemistry, but so is cannabis… combine the two, and the possibilities are endless. EDITOR-AT-LARGE MELISSA HUTSELL GIFT GUIDE SHILOH WISHAM People all over the world have found love through the industry. Now, couples can celebrate their love for each GRAPHIC DESIGNER SIERRA FONG | NATHAN WELLS other, and the herb, in true canna-style. All the products needed for cannabis-themed nuptials -- from hemp dresses to Bud Bars – are showcased at the Cannabis Wedding Expo (Pg. 20), coming to San Francisco this February and Los COVER SHOT KENESHA FACELLO Angeles in March. The science of cannabis is still in its infancy, but research has so far shown us that the plant’s therapeutic benefits CONTRIBUTORS extend into the bedroom.
    [Show full text]
  • Phivida Holdings Inc
    PHIVIDA HOLDINGS INC. (the “Company” or the “Issuer”) Form 2A LISTING STATEMENT Dated December 18, 2017 TABLE OF CONCORDANCE This table provides the corresponding section to page numbers between the Canadian Securities Exchange Form 2A Listing Statement and the Company’s Final Long Form Non-Offering Prospectus dated November 17, 2017 (the “Prospectus”), filed under the Company’s profile on SEDAR (www.sedar.com), a copy of which is attached hereto as Schedule “A”. Information Required Corresponding Item Prospectus by Form 2A Listing Statement in Prospectus Page Number 1. Table of Contents Table of Contents 1-2 2. Corporate Structure 2.1 Name Name, Address and Incorporation; 13 –14 Intercorporate Relationships 2.2 Incorporating Statute Name, Address and Incorporation; 13 Intercorporate Relationships 2.3 Intercorporate Relationships Summary of Prospectus 9 – 13 Intercorporate Relationships 14 2.4 Requalifying / Fundamental Change Not applicable – 2.5 Non-corporate / non-Canadian Not applicable – Issuers 3. General Development of the Business 3.1 Development of business over past 3 Description of the Business 14 – 40 financial years (and subsequent period) 3.2 Significant Acquisitions and Description of the Business 14 – 40 Dispositions 3.3 Material trends, commitment, event, Not applicable - uncertainty Information Required Corresponding Item Prospectus by Form 2A Listing Statement in Prospectus Page Number 4. Narrative Description of the Business 4.1 Description of business Description of the Business 14 – 40 4.1(1)(a) Objectives within
    [Show full text]
  • Indus Holdings, Inc
    INDUS HOLDINGS, INC. LISTING STATEMENT CSE FORM 2A APRIL 23, 2019 INDUS HOLDING COMPANY FORM 2A – LISTING STATEMENT Page 1 The Resulting Issuer (as defined herein) is an entity that derives all of its revenues from the cannabis industry in certain U.S. states, which industry is illegal under U.S. federal law. The Resulting Issuer is directly involved in the cannabis industry through the production, cultivation, distribution and sale of medical and adult-use cannabis in the State of California, which has regulated such activity. The cultivation, sale and use of cannabis is illegal under federal law pursuant to the U.S. Controlled Substances Act of 1970 (the “Controlled Substances Act”). Under the Controlled Substances Act, the policies and regulations of the United States Federal Government and its agencies are that cannabis has no medical benefit and a range of activities including cultivation and the personal use of cannabis is prohibited. Even in those states in which the use of marijuana has been legalized, its use, cultivation, sale and distribution remains a violation of federal law. The Supremacy Clause of the United States Constitution establishes that the United States Constitution and federal laws made pursuant to it are paramount and in case of conflict between federal and state law, the federal law shall apply. Any person connected to the marijuana industry in the U.S. may be at risk of federal criminal prosecution and civil liability in the United States. Any investments may be subject to civil or criminal forfeiture and total loss. Since federal law criminalizing the use of marijuana is not pre-empted by state laws that legalize its use, strict enforcement of federal law regarding marijuana would harm the Resulting Issuer’s business, prospects, results of operation, and financial condition.
    [Show full text]